• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Catalog Number BXA072902E
Device Problems Complete Blockage (1094); Device Stenosis (4066)
Patient Problems Obstruction/Occlusion (2422); Thrombosis/Thrombus (4440); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/19/2021
Event Type  Injury  
Manufacturer Narrative
Requests were emailed to the study coordinator to further clarify the event.The responses were captured in the event description.A review of the manufacturing records indicated the device met pre-release manufacturing specifications.The device remains implanted in the patient.Therefore a device evaluation could not be performed.Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
On (b)(6) 2019, the patient was endovascular treated for a pararenal aneurysm of the abdominal aorta with a customized 4-branched stent graft component (cook medical).A gore viabahn® vbx balloon expandable endoprosthesis was used to extend the branch into the celiac trunk.Access was gained via cut down to the femoral artery.The physician reported that there was no difficulty during implantation of the device, and that the device was patent at the end of the procedure.During an unscheduled phone call of the patient with the hospital on (b)(6) 2021, the patient reported that a follow up computed angiography tomography showed that the device has occluded.Reportedly no permanent impairment of a body structure or function did occur.No preventative medical or surgical intervention was performed.Hospitalization was not required.The physician stated that the primary relationship of the occlusion is unknown.During a scheduled follow up phone call of the hospital with the patient on (b)(6) 2022, the patient confirmed that the device remains occluded, that he is doing well, and that a reintervention has neither been performed nor is a reintervention planned.The physician confirmed that the patient is totally asymptomatic and that no further interventions were required.
 
Manufacturer Narrative
H6: code b15: radiographic images were requested from the hospital.The images were released and shared with gore for evaluation.The imaging evaluation summary states the following: three time-points available for evaluation: pre-implantation cta dated (b)(6) 2018, post-implantation cta dated (b)(6) 2019 and post-implantation cta dated (b)(6) 2021.Comparison imaging appears to show: on (b)(6) 2019: diameter at the circumferential vbx inside the cook device appears to be 8 mm.Diameter 5 mm distal to the circumferential device location at the outer cook device wall appears to be 4.8 mm.On (b)(6) 2021, circumferential vbx device within the cook device appears to have moved or shifted toward the inner side of the cook device.Diameter at the circumferential vbx inside the cook device appears to be 7.6 mm.Diameter 5 mm distal to the circumferential device location at the outer device wall appears to be 2.1 mm.The vbx device appears to be occluded.Flow can be visualized distal to the vbx device in the celiac artery.
 
Manufacturer Narrative
Conclusion; a review of the manufacturing records indicated the lot met pre-release manufacturing specifications.The vbx device itself remains implanted in the patient.Therefore a product evaluation could not be performed.Radiographic images were requested from the hospital.Images of three time-points were released and shared with gore for evaluation.The imaging evaluation summary states the following: 6/20/2019 - diameter at the circumferential vbx inside the cook device appears to be ~8 mm.- diameter 5 mm distal to the circumferential device location at the outer cook device wall appears to be ~4.8 mm.10/19/2021 - circumferential vbx device within the cook device appears to have moved or shifted toward the inner side of the cook device - diameter at the circumferential vbx inside the cook device appears to be ~7.6 mm.- diameter 5 mm distal to the circumferential device location at the outer device wall appears to be ~2.1 mm.- the vbx device appears to be occluded.- flow can be visualized distal to the vbx device in the celiac artery.The reported information, including review of clinical images provided to gore, does not reasonably suggest a potential malfunction.Post-procedural images showed that circumferential vbx device within the cook device appears to have moved or shifted toward the inner side of the cook device.There appears to be no relationship with the reported vbx device occlusion.The cause of the reported vbx device occlusion could not be established with the information provided and the subsequent investigation.The instructions for use state the following: intended use/indications the gore® viabahn® vbx balloon expandable endoprosthesis is indicated for endovascular grafting of peripheral vessels.Therefore stenting the celiac trunk with a vbx device is off-label use.Furthermore, the instructions for use state the following: hazards and adverse events device related: complications and adverse events can occur when using any endovascular device.These complications include,but are not limited to: stenosis, thrombosis or occlusion;.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
sibylle staerk
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key14943197
MDR Text Key295406529
Report Number2017233-2022-03100
Device Sequence Number1
Product Code PRL
Combination Product (y/n)Y
Reporter Country CodeIT
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 09/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/07/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/02/2021
Device Catalogue NumberBXA072902E
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/13/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/02/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age64 YR
Patient SexMale
Patient Weight97 KG
-
-